Orphan Drugs: Coté Orphan Offers New Clinical Research Organization (CRO) Services
Coté Orphan, a regulatory affairs advisory firm located in Silver Spring, Maryland, announces this week, new Clinical Research Organization (CRO) services that will help companies navigate the clinical trials process for orphan drugs. The CRO services will help with the design of clinical trials for orphan drugs to meet the regulatory requirements for both the FDA and European Medicines Agency (EMA).
According to Dr. Timothy Coté, CEO of Coté Orphan :
“ … By designing trials processes that are already in compliance with current regulations, we are helping to drastically cut the time to market for these types of drugs. This, in tandem with our other planning and execution services, puts us in a position to provide a one-stop-shop service to clients – from inception through to acceptance.”
Coté Orphan is currently at Exhibit #2 at the World Orphan Drug Congress in Brussels, November 12-14, 2014.
Logo courtesy of Coté Orphan, LLC .
Copyright © 2012-2014, Orphan Druganaut Blog. All rights reserved.